California Strengthens Equal Pay Enforcement With SB 642

California Strengthens Equal Pay Enforcement With SB 642

• News

January 15, 2026 | Sacramento, CA — MedLegalNews.com — California continues to lead the nation in workplace equity reforms with the passage of SB 642 (Limón), legislation that significantly expands state equal pay laws. The law broadens key definitions, extends the statute of limitations for wage discrimination claims, and clarifies categories of unlawful pay practices. […]

California Strengthens Equal Pay Enforcement With SB 642 Read Post »

El Presupuesto 2026 Confirma el Problema Real — y el Fracaso de la Política Pública

El Presupuesto 2026 Confirma el Problema Real — y el Fracaso de la Política Pública

• News

El Presupuesto de California 2026–27 no deja espacio para distracciones ni interpretaciones engañosas. El Estado de California ha reconocido formalmente que la falla central del Fondo Fiduciario de Beneficios por Lesiones Subsecuentes (Subsequent Injuries Benefits Trust Fund, SIBTF) es el retraso: retrasos de años que niegan a trabajadores permanentemente discapacitados el acceso oportuno a los beneficios que la ley les

El Presupuesto 2026 Confirma el Problema Real — y el Fracaso de la Política Pública Read Post »

Budget 2026 Confirms the Real Problem—and the Policy Failure

Budget 2026 Confirms the Real Problem—and the Policy Failure

• News

January 14, 2026 | Sacramento, CA — MedLegalNews.com — The California 2026–27 Budget leaves no room for misdirection. The State of California has formally acknowledged that the central failure of the Subsequent Injuries Benefits Trust Fund (SIBTF) is delay—years-long delays that deny permanently disabled workers timely access to benefits they are legally owed. The January

Budget 2026 Confirms the Real Problem—and the Policy Failure Read Post »

Critics Say Assemblymember Liz Ortega Was Misled Into Supporting SIBTF Reforms That Targeted Disabled Californians

Critics Say Assemblymember Liz Ortega Was Misled Into Supporting SIBTF Reforms That Targeted Disabled Californians

• News

January 13, 2026 | Sacramento, CA — MedLegalNews.com — California Assemblymember Liz Ortega, a prominent labor leader and Chair of the Assembly Committee on Labor and Employment, has come under sustained criticism from disability advocates and workers’ compensation attorneys who argue that she was misled — or “hoodwinked,” in their words — into advancing policy proposals that

Critics Say Assemblymember Liz Ortega Was Misled Into Supporting SIBTF Reforms That Targeted Disabled Californians Read Post »

Questions Raised Over 2024 RAND SIBTF Liability Study

Questions Raised Over 2024 RAND SIBTF Liability Study

• News, Medical

January 7, 2026 — An investigation by The Jacobi Journal reports that the RAND Corporation’s 2024 study of California’s Subsequent Injuries Benefits Trust Fund (SIBTF) may have overstated the fund’s projected unfunded liability by approximately $6.75 billion, or about 632%, compared with the Journal’s recalculated estimate. The RAND study’s headline figure of a $7.9 billion

Questions Raised Over 2024 RAND SIBTF Liability Study Read Post »

California’s SB 40 Caps Insulin Costs: Key Details for Insurers and Patients

California’s SB 40 Caps Insulin Costs: Key Details for Insurers and Patients

• News

January 5, 2026 | Sacramento, CA — MedLegalNews.com — Starting January 1, 2026, California implements SB 40, landmark legislation designed to address the state’s ongoing insulin affordability crisis. The law caps out-of-pocket insulin costs for patients covered by large, state-regulated health insurers, limiting a 30-day supply to a $35 copay. Additionally, the suggested retail price

California’s SB 40 Caps Insulin Costs: Key Details for Insurers and Patients Read Post »

California Lawmakers Target Licensing Barriers for Alternative Birth Centers Under AB 55

California Lawmakers Target Licensing Barriers for Alternative Birth Centers Under AB 55

• News

January 3, 2026 | Sacramento, CA — MedLegalNews.com — California is taking another step toward reshaping its maternal healthcare framework as lawmakers revisit long-standing regulatory hurdles affecting alternative birth centers. AB 55 (Bonta) focuses on expanding access to licensed, midwife-led birth centers while addressing persistent reimbursement challenges under Medi-Cal—an issue that has limited care options

California Lawmakers Target Licensing Barriers for Alternative Birth Centers Under AB 55 Read Post »

Johnson & Johnson Slapped With $1.5 Billion Talc Verdict in Baltimore Mesothelioma Case

Johnson & Johnson Slapped With $1.5 Billion Talc Verdict in Baltimore Mesothelioma Case

• News

December 31, 2025 | Los Angeles, CA — MedLegalNews.com — A Baltimore jury has delivered one of the most consequential talc-related verdicts of the year, ordering Johnson & Johnson to pay more than $1.5 billion to a woman who developed mesothelioma after decades of alleged exposure to the company’s talc-based products. According to trial testimony,

Johnson & Johnson Slapped With $1.5 Billion Talc Verdict in Baltimore Mesothelioma Case Read Post »

Punitive Damages Denied in Nursing Home Death Lawsuit After Appeals Court Review

Punitive Damages Denied in Nursing Home Death Lawsuit After Appeals Court Review

• News

December 29, 2025 | Tallahassee, FL — MedLegalNews.com — A Florida state appeals court has upheld a lower court ruling denying a request to pursue punitive damages in a wrongful death lawsuit involving a nursing home resident who suffered a rare spinal fracture prior to death. The appellate panel concluded that the evidence presented failed

Punitive Damages Denied in Nursing Home Death Lawsuit After Appeals Court Review Read Post »

Purdue Pharma’s $7.4 Billion Chapter 11 Plan Poised for Court Confirmation

Purdue Pharma’s $7.4 Billion Chapter 11 Plan Poised for Court Confirmation

• News

December 24, 2025 | Washington, D.C. — MedLegalNews.com — Purdue Pharma’s long-running Chapter 11 bankruptcy case is nearing a decisive moment, as a federal court prepares to confirm a revised $7.4 billion reorganization plan designed to resolve thousands of opioid-related claims nationwide. The confirmation would mark one of the most significant mass tort resolutions in

Purdue Pharma’s $7.4 Billion Chapter 11 Plan Poised for Court Confirmation Read Post »

Scroll to Top